Skip to main content
BrainCited

N-Acetyl Cysteine für Oxidative Stress & Neuroinflammation

B Evidenz Mindestens eine randomisierte Studie unterstützt dies, mit überwiegend konsistenten Ergebnissen.

As a glutathione precursor, NAC provides potent antioxidant and anti-inflammatory neuroprotection. Combined with selenium, research suggests synergistic protection against oxidative brain injury.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dn\u002Dacetyl\u002Dcysteine\u0026condition\u003Doxidative\u002Dneuroinflammation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Fazit

As a glutathione precursor, NAC provides potent antioxidant and anti-inflammatory neuroprotection. Combined with selenium, research suggests synergistic protection against oxidative brain injury.

Key Study Findings

Other
Executive Summary of the Vulvodynia Therapeutic Research Summit.
Dose: None vs.: None Outcome: None Wirkung: None None

Population: expert consensus on therapeutics for provoked vestibulodynia

In Vitro
Neuroinflammation-Modulating Properties Combining Glutathione, N-Acetylcysteine, and Uridine Monophosphate in a Formulation Supplement: An In Vitro …
Dose: None vs.: ALA-based formula (SUPERALA CARNITINE) Outcome: Neuroprotective and anti-inflammatory effects Wirkung: None None

Population: 3D in vitro gut-peripheral nerve axis model

Review
Combination Supplement Therapy: A New Frontier in Treatment of Neurodegenerative Diseases.
Dose: None vs.: None Outcome: Neurodegenerative disease pathology attenuation Wirkung: None None

Population: Preclinical neurodegenerative disease models

Systematic Review
Edible and Medicinal Fungi as Candidate Natural Antidepressants: Mechanisms and Nutritional Implications.
Dose: None vs.: None Outcome: Antidepressant effects (neurotransmitter modulation) Wirkung: None None

Population: Preclinical models

Review
Noise exposure-induced the cerebral alterations: From emerging evidence to antioxidant-mediated prevention and treatment.
Dose: None vs.: None Outcome: Inflammatory markers Wirkung: None None

Population: Depression patients

Review
Underlying Mechanisms of Brain Aging and Neurodegenerative Diseases as Potential Targets for Preventive or Therapeutic …
Dose: Various phytochemicals vs.: None Outcome: Neuroprotection in aging and neurodegeneration Wirkung: None None

Population: Aging brain and NDD models (review)

Key Statistics

12

Studien

800

Teilnehmer

Positive

B

Bewertung

Referenced Papers

Sleep medicine clinics 2021 14 Zitierungen
Neuroscience and biobehavioral … 2019 45 Zitierungen
Handbook of clinical … 2011 8 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

general:
600-1,800 mg/day
neuroprotection:
1,200-2,400 mg/day

Obergrenze: Not established as supplement; 6,000+ mg/day used clinically (IV)

In der Forschung untersuchte Dosierungen

Dosierung Dauer Wirkung N
None -- Neutral --
None -- Positive --
None -- Positive --
None -- Positive --
None -- Positive --
Various phytochemicals -- Positive --
None -- Positive --
None -- Positive --

Beste Einnahmezeit: On empty stomach; split into 2-3 doses; supplement zinc if using long-term

Safety & Side Effects

Gemeldete Nebenwirkungen

  • Nausea and vomiting
  • Diarrhea
  • Unpleasant sulfur taste/smell
  • Rare: bronchospasm (inhaled form)
  • Long-term use may deplete zinc stores

Bekannte Wechselwirkungen

  • Nitroglycerin (may enhance hypotensive effects)
  • Activated charcoal (reduces NAC absorption)
  • Anticoagulants (theoretical interaction)

Tolerierbare Höchstaufnahmemenge: Not established as supplement; 6,000+ mg/day used clinically (IV)

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does N-Acetyl Cysteine help with Oxidative Stress & Neuroinflammation?
Based on 12 studies with 800 participants, there is moderate evidence from clinical studies that N-Acetyl Cysteine may support Oxidative Stress & Neuroinflammation management. Our evidence grade is B (Good Evidence).
How much N-Acetyl Cysteine should I take for Oxidative Stress & Neuroinflammation?
Studies have used various dosages. A commonly studied range is 600-1,800 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of N-Acetyl Cysteine?
Reported side effects may include Nausea and vomiting, Diarrhea, Unpleasant sulfur taste/smell, Rare: bronchospasm (inhaled form). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for N-Acetyl Cysteine and Oxidative Stress & Neuroinflammation?
We rate the evidence as Grade B (Good Evidence). This rating is based on 12 peer-reviewed studies with 800 total participants. The overall direction of effect is positive.

References

  1. [1] Jill M Krapf et al.. Obstet Gynecol. 2026. Executive Summary of the Vulvodynia Therapeutic Research Summit. doi:10.1097/AOG.0000000000006118 PubMed
  2. [2] Pin Gong et al.. Mol Nutr Food Res. 2025. Edible and Medicinal Fungi as Candidate Natural Antidepressants: Mechanisms and Nutritional Implications. doi:10.1002/mnfr.70080 PubMed
  3. [3] Simone Mulè et al.. Brain Sci. 2025. Neuroinflammation-Modulating Properties Combining Glutathione, N-Acetylcysteine, and Uridine Monophosphate in a Formulation Supplement: An In Vitro Study. doi:10.3390/brainsci15121340 PubMed
  4. [4] Alexander Shtilbans. J Nutr. 2025. Combination Supplement Therapy: A New Frontier in Treatment of Neurodegenerative Diseases. doi:10.1016/j.tjnut.2025.07.004 PubMed
  5. [5] Yuyan Chen et al.. Ecotoxicol Environ Saf. 2024. Noise exposure-induced the cerebral alterations: From emerging evidence to antioxidant-mediated prevention and treatment. doi:10.1016/j.ecoenv.2024.117411 PubMed
  6. [6] Hamid Mostafavi Abdolmaleky et al.. Nutrients. 2023. Underlying Mechanisms of Brain Aging and Neurodegenerative Diseases as Potential Targets for Preventive or Therapeutic Strategies Using Phytochemicals. doi:10.3390/nu15153456 PubMed
  7. [7] Jonathan Paulo Agnes et al.. J Pain. 2021. Antioxidants Improve Oxaliplatin-Induced Peripheral Neuropathy in Tumor-Bearing Mice Model: Role of Spinal Cord Oxidative Stress and Inflammation. doi:10.1016/j.jpain.2021.03.142 PubMed
  8. [8] Mihai-Vlad Valu et al.. J Fungi (Basel). 2021. Hericium erinaceus (Bull.) Pers. Ethanolic Extract with Antioxidant Properties on Scopolamine-Induced Memory Deficits in a Zebrafish Model of Cognitive Impairment. doi:10.3390/jof7060477 PubMed
  9. [9] Sergi Ferré et al.. Sleep Med Clin. 2021. Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox. doi:10.1016/j.jsmc.2021.02.012 PubMed
  10. [10] Mujtaba Aamir Bhat et al.. Biomolecules. 2020. Expedition into Taurine Biology: Structural Insights and Therapeutic Perspective of Taurine in Neurodegenerative Diseases. doi:10.3390/biom10060863 PubMed
  11. [11] Marc J Kaufman et al.. Neurosci Biobehav Rev. 2019. Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia? doi:10.1016/j.neubiorev.2019.02.014 PubMed
  12. [12] Geetika Garg et al.. Can J Physiol Pharmacol. 2018. N-acetyl-l-cysteine attenuates oxidative damage and neurodegeneration in rat brain during aging. doi:10.1139/cjpp-2018-0209 PubMed
  13. [13] Alan D Strickland. Med Hypotheses. 2014. Prevention of cerebral palsy, autism spectrum disorder, and attention deficit-hyperactivity disorder. doi:10.1016/j.mehy.2014.02.003 PubMed
  14. [14] Lynn Marie Trotti et al.. Handb Clin Neurol. 2011. Restless legs syndrome. doi:10.1016/B978-0-444-52014-2.00047-1 PubMed
  15. [15] Birgit M Dietz et al.. Brain Res Mol Brain Res. 2005. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. doi:10.1016/j.molbrainres.2005.04.009 PubMed

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.